Comment
The cost-effectiveness of misoprostol
- PMID: 1898976
Item in Clipboard
Comment
The cost-effectiveness of misoprostol
JAMA.
.
No abstract available
Comment on
-
Cost-effectiveness of misoprostol for prophylaxis against nonsteroidal anti-inflammatory drug-induced gastrointestinal tract bleeding.JAMA. 1990 Jul 4;264(1):41-7. JAMA. 1990. PMID: 2113103
Similar articles
-
Misoprostol.Med Lett Drugs Ther. 1989 Mar 10;31(787):21-2. Med Lett Drugs Ther. 1989. PMID: 2493124 No abstract available.
-
[Cost-effectiveness of preventive treatment with misoprostol in non-steroidal anti-inflammatory agents related gastric ulcers].Gastroenterol Clin Biol. 1991;15(5):399-404. Gastroenterol Clin Biol. 1991. PMID: 1906413 Clinical Trial. French.
-
Misoprostol and ulcer prophylaxis.Lancet. 1989 Jan 28;1(8631):212-3. doi: 10.1016/s0140-6736(89)91220-8. Lancet. 1989. PMID: 2563111 No abstract available.
-
A review of the therapeutic efficacy of misoprostol, a prostaglandin E1 analogue.S Afr Med J. 1988 Jul 2;74 Suppl:56-8. S Afr Med J. 1988. PMID: 3133797 Review. No abstract available.
-
Recent advances in defining the role of misoprostol in rheumatology.J Rheumatol Suppl. 1990 Feb;20:50-3. J Rheumatol Suppl. 1990. PMID: 2109076 Review.
Cited by
-
Formulary management of antiulcer drugs: economic considerations.Pharmacoeconomics. 1994 Apr;5(4):313-34. doi: 10.2165/00019053-199405040-00006. Pharmacoeconomics. 1994. PMID: 10147240 Review.
-
Misoprostol: pharmacoeconomics of its use as prophylaxis against gastroduodenal damage induced by nonsteroidal anti-inflammatory drugs.Pharmacoeconomics. 1993 Feb;3(2):140-71. doi: 10.2165/00019053-199303020-00007. Pharmacoeconomics. 1993. PMID: 10146962 Review.
-
Diclofenac/misoprostol. A review of its pharmacology and therapeutic efficacy in painful inflammatory conditions.Drugs Aging. 1995 Nov;7(5):372-93. doi: 10.2165/00002512-199507050-00005. Drugs Aging. 1995. PMID: 8573992 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
